§ Dr. Roger Thomasasked the Secretary of State for Social Services if he will extend the availablity of mucolytic and expectorant medications available under the 140W limited lists of drugs available for respiratory diseases in areas with an unusually high incidence of such diseases, some industrially induced; and if he will make a statement.
§ Mr. Kenneth ClarkeWe will shortly be setting up a committee to keep the selected list under review, to ensure that it continues to meet all clinical needs at the lowest possible cost to the National Health Service. One of the first tasks of this committee will be to reconsider the position of mucolytics and expectorants if they are asked to do so by the manufacturers.